Evolv Technologies Holdings, Inc. (NASDAQ:EVLV – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $9.1250.
EVLV has been the topic of several research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Evolv Technologies in a research report on Tuesday, April 21st. Zacks Research raised shares of Evolv Technologies from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 27th.
Get Our Latest Stock Analysis on Evolv Technologies
Evolv Technologies Stock Performance
Evolv Technologies (NASDAQ:EVLV – Get Free Report) last posted its quarterly earnings data on Tuesday, May 12th. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.03. Evolv Technologies had a negative return on equity of 34.80% and a negative net margin of 22.75%.The company had revenue of $46.33 million for the quarter, compared to the consensus estimate of $44.23 million. Research analysts forecast that Evolv Technologies will post -0.18 EPS for the current fiscal year.
Trending Headlines about Evolv Technologies
Here are the key news stories impacting Evolv Technologies this week:
- Positive Sentiment: Evolv reported Q1 EPS of about -$0.02 to -$0.03, beating estimates, and revenue of $46.33 million, also ahead of forecasts. Article Title
- Positive Sentiment: The company raised its 2026 revenue guidance to $175 million-$180 million, slightly above consensus, signaling management confidence in growth. Article Title
- Positive Sentiment: Bank of America Stadium highlighted efficient game-day operations using Evolv Express, and announced a renewal/upgrade, which supports product adoption and customer retention. Article Title
- Positive Sentiment: Management announced an Investor Day on June 9, which could help showcase strategy, growth plans, and product momentum. Article Title
- Neutral Sentiment: Traders bought an unusually high number of call options, suggesting increased speculation and potential for elevated trading activity. Article Title
- Negative Sentiment: Evolv also clarified that some market data websites misrepresented its Q1 results, which may have created confusion and added short-term pressure on the stock. Article Title
Insiders Place Their Bets
In other Evolv Technologies news, Director Michael Ellenbogen sold 91,771 shares of the business’s stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $5.10, for a total transaction of $468,032.10. Following the sale, the director owned 2,083,961 shares in the company, valued at approximately $10,628,201.10. The trade was a 4.22% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 11.30% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. IFC & Insurance Marketing Inc. purchased a new stake in shares of Evolv Technologies in the 4th quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd grew its position in Evolv Technologies by 471.0% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 6,806 shares of the company’s stock worth $49,000 after purchasing an additional 5,614 shares in the last quarter. State of Alaska Department of Revenue purchased a new position in Evolv Technologies during the 3rd quarter worth approximately $60,000. FNY Investment Advisers LLC raised its stake in Evolv Technologies by 48.3% during the 4th quarter. FNY Investment Advisers LLC now owns 8,897 shares of the company’s stock valued at $63,000 after purchasing an additional 2,897 shares during the period. Finally, AlphaCore Capital LLC acquired a new stake in Evolv Technologies during the 4th quarter valued at $72,000. 66.65% of the stock is owned by hedge funds and other institutional investors.
About Evolv Technologies
Evolv Technologies, Inc is a publicly traded American security technology company that develops and markets AI-driven weapons detection and screening solutions. The company’s proprietary platform combines advanced sensors, computer vision software and machine learning algorithms to identify potential threats—such as firearms and knives—while minimizing false positives and preserving high throughput. Evolv’s systems are designed to replace or supplement traditional metal detectors and manual bag checks in high-traffic venues.
The company’s flagship product, Evolv Express, integrates seamlessly into existing security checkpoints, allowing guests to pass through without stopping or emptying their pockets.
Read More
- Five stocks we like better than Evolv Technologies
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Evolv Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolv Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
